Search

everythinglearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

High testosterone increases heart disease risk in women with PCOS.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Herbal treatments can help manage PCOS symptoms.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Diabetes often causes various skin problems and complications.